REV3L
Basic information
Region (hg38): 6:111299028-111483715
Links
Phenotypes
GenCC
Source:
- Mobius syndrome (Limited), mode of inheritance: Unknown
- Mobius syndrome (Supportive), mode of inheritance: AD
- Mobius syndrome (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (271 variants)
- not_provided (113 variants)
- REV3L-related_disorder (36 variants)
- not_specified (2 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
- Carcinoma_of_colon (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the REV3L gene is commonly pathogenic or not. These statistics are base on transcript: NM_001372078.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 44 | 15 | 59 | |||
| missense | 253 | 43 | 15 | 312 | ||
| nonsense | 2 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 1 | 256 | 87 | 30 |
Highest pathogenic variant AF is 0.000007663188
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| REV3L | protein_coding | protein_coding | ENST00000358835 | 32 | 184685 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 7.05e-16 | 125715 | 0 | 22 | 125737 | 0.0000875 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.47 | 1315 | 1.59e+3 | 0.826 | 0.0000808 | 20622 |
| Missense in Polyphen | 329 | 566.28 | 0.58099 | 7303 | ||
| Synonymous | 0.556 | 544 | 561 | 0.970 | 0.0000278 | 5956 |
| Loss of Function | 10.0 | 9 | 135 | 0.0669 | 0.00000765 | 1720 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000153 | 0.000152 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.000143 | 0.000139 |
| European (Non-Finnish) | 0.000110 | 0.000105 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.0000333 | 0.0000327 |
| Other | 0.000175 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of the DNA polymerase zeta complex, an error-prone polymerase specialized in translesion DNA synthesis (TLS). Lacks an intrinsic 3'-5' exonuclease activity and thus has no proofreading function. {ECO:0000269|PubMed:24449906}.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);DNA Repair;Purine metabolism;Pyrimidine metabolism;Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass
(Consensus)
Recessive Scores
- pRec
- 0.195
Intolerance Scores
- loftool
- 0.218
- rvis_EVS
- -2.1
- rvis_percentile_EVS
- 1.55
Haploinsufficiency Scores
- pHI
- 0.860
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.761
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rev3l
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; neoplasm; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- DNA-dependent DNA replication;error-prone translesion synthesis;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- nucleoplasm;nucleolus;zeta DNA polymerase complex
- Molecular function
- nucleotide binding;DNA binding;DNA-directed DNA polymerase activity;protein binding;3'-5' exonuclease activity;metal ion binding;4 iron, 4 sulfur cluster binding